{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:22:23Z","timestamp":1775510543389,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jpedhc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.pedhc.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T10:14:18Z","timestamp":1535710458000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management"],"prefix":"10.1016","volume":"32","author":[{"given":"Jessica L.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedhc.2018.02.005_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.autrev.2005.09.011","article-title":"Juvenile idiopathic arthritis","volume":"5","author":"Borchers","year":"2006","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R","article-title":"Teratogen update: Reproductive risks of leflunomide (Arava); A pyrimidine synthesis inhibitor: Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child","volume":"63","author":"Brent","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib9000","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","article-title":"Clinical outcome measures in juvenile idiopathic arthritis","volume":"14","author":"Consolaro","year":"2016","journal-title":"Pediatric Rheumatology"},{"issue":"Suppl. 1","key":"10.1016\/j.pedhc.2018.02.005_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000229757","article-title":"Juvenile idiopathic arthritis: Classification, clinical presentation and current treatments","volume":"72","author":"Dannecker","year":"2009","journal-title":"Hormone Research"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0030","first-page":"2507","article-title":"Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis","volume":"31","author":"Eberhard","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/rheumatology\/kep383","article-title":"Possible environmental determinants of juvenile idiopathic arthritis","volume":"49","author":"Ellis","year":"2010","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1542\/pir.33-7-303","article-title":"Juvenile idiopathic arthritis","volume":"33","author":"Espinosa","year":"2012","journal-title":"Pediatrics in Review"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0045","series-title":"EULAR bulletin no. 4: Nomenclature and classification or arthritis in children","author":"European League Against Rheumatism","year":"1977"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40272-013-0053-1","article-title":"Tocilizumab: A review of its use in the treatment of juvenile idiopathic arthritis","volume":"15","author":"Frampton","year":"2013","journal-title":"Pediatric Drugs"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","article-title":"Juvenile idiopathic arthritis: Diagnosis and treatment","volume":"3","author":"Giancane","year":"2016","journal-title":"Rheumatology Therapy"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11882-013-0351-2","article-title":"Update on the treatment of juvenile idiopathic arthritis","volume":"13","author":"Harris","year":"2013","journal-title":"Current Allergy & Asthma Reports"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.24187","article-title":"Association of the IL2RA\/CD25 gene with juvenile idiopathic arthritis","volume":"60","author":"Hinks","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","article-title":"Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study","volume":"145","author":"Lehman","year":"2004","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrrheum.2013.105","article-title":"Advances from clinical trials in juvenile idiopathic arthritis","volume":"9","author":"Lovell","year":"2013","journal-title":"Nature Reviews. Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0080","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","article-title":"Long-term outcome in patients with juvenile idiopathic arthritis","volume":"46","author":"Minden","year":"2002","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0085","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1111\/jpc.12218","article-title":"Juvenile idiopathic arthritis in the new world of biologics","volume":"49","author":"Ostring","year":"2013","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0090","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0095","first-page":"625","article-title":"Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis","volume":"17","author":"Ravelli","year":"1999","journal-title":"Clinical & Experimental Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0100","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","article-title":"2013 Update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0105","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis & Rheumatism"},{"issue":"9636","key":"10.1016\/j.pedhc.2018.02.005_bib0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: A randomized, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0115","series-title":"Arava (leflunomide) [package insert]","author":"Sanofi-Aventis","year":"2016"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0120","first-page":"1826","article-title":"Juvenile rheumatoid arthritis in African Americans","volume":"49","author":"Schwarz","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0125","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"New England of Journal"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0130","series-title":"Pediatric and neonatal dosage handbook","author":"Taketomo","year":"2017"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","article-title":"Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group","volume":"41","author":"Van Rossum","year":"1998","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care & Research (Hoboken)"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2009.08.001","article-title":"An overview of genetics of paediatric rheumatic diseases","volume":"23","author":"Woo","year":"2009","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1016\/j.pedhc.2018.02.005_bib0150","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","article-title":"Triamcinolone acetonid and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: A double-blind trial","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524517306533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524517306533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T11:07:51Z","timestamp":1535713671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524517306533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0891524517306533"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2018.02.005","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}